DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | - | ₹37 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr |
What is the latest Long Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹25 Cr |
How is Long Term Provisions of DIVIS LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹37 Cr | 19.35 | |
| Mar2023 | ₹31 Cr | 16.06 | |
| Mar2022 | ₹27 Cr | 5.07 | |
| Mar2021 | ₹25 Cr | - | |
Compare Long Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹168,950.9 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
| MANKIND PHARMA | ₹91,867.7 Cr | -2.4% | 3.2% | -3.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.7% |
2.5% |
12.3% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses